The World Local Production Forum is being held this week amid wide-ranging discussions on how to give lower-resourced countries more self-sufficiency in medicines and vaccine manufacturing.
Efforts to build up local, sustainable drug manufacturing capacity in low- and middle-income countries (LMICs) will not work unless “intellectual property barriers” such as patents and data protection are addressed, according to a group of NGOs, health activists and medical charities including Health Action International, Unitaid and Public Citizen.
“Building a bridge to a well distributed, capacitated and sustainable manufacturing capacity in LMIC regions will be essential to their...
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
The UK regulator approved 16 medicines containing a new active substance in the first half of this year, while the European Commission issued marketing authorizations for 20 NAS-containing drugs.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
